Stefan Kaiser

Stefan Kaiser

Auto-generated profile, based on publicly available information

Stefan Kaiser

Department of Psychiatry, University Hospitals of Geneva, Geneva, Switzerland

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2019 in Frontiers in Psychiatry
Verified
Journal Article
Open access
MCMarie Chieze
Marie Chieze
SHSamia Hurst
Samia Hurst
SKStefan Kaiser
Stefan Kaiser
OSOthman Sentissi
Othman Sentissi
Background: Determining the clinical effects of coercion is a difficult challenge, raising ethical, legal, and methodological questions. Despite limited scientific evidence on effectiveness, coercive measures are frequently used, especially in psychiatry. This systematic review aims to search for effects of seclusion and restraint on psychiatric inpatients with wider inclusion of outcomes and study designs than former reviews. Methods: A systematic search was conducted following PRISMA guidelines, primarily through Pubmed, Embase, and CENTRAL. Interventional and prospective observational studies on effects of seclusion and restraint on psychiatric inpatients were included. Main search keywords were restraint, seclusion, psychiatry, effect, harm, efficiency, efficacy, effectiveness, and quality of life. Results: Thirty-five articles were included, out of 6,854 records. Studies on the effects of seclusion and restraint in adult psychiatry comprise a wide range of outcomes and designs. The identified literature provides some evidence that seclusion and restraint have deleterious physical or psychological consequences. Estimation of post-traumatic stress disorder incidence after intervention varies from 25% to 47% and, thus, is not negligible, especially for patients with past traumatic experiences. Subjective perception has high interindividual variability, mostly associated with negative emotions. Effectiveness and adverse effects of seclusion and restraint seem to be similar. Compared to other coercive measures (notably forced medication), seclusion seems to be better accepted, while restraint seems to be less tolerated, possibly because of the perception of seclusion as "non-invasive." Therapeutic interaction appears to have a positive influence on coercion perception. Conclusion: Heterogeneity of the included studies limited drawing clear conclusions, but the main results identified show negative effects of seclusion and restraint. These interventions should be used with caution and as a last resort. Patients' preferences should be taken into account when deciding to apply these measures. The therapeutic relationship could be a focus for improvement of effects and subjective perception of coercion. In terms of methodology, studying coercive measures remains difficult but, in the context of current research on coercion reduction, is needed to provide workable baseline data and potential targets for interventions. Well-conducted prospective cohort studies could be more feasible than randomized controlled trials for interventional studies.

1 September 2020 in NeuroImage
Verified
Journal Article
Open access
Joaquim RaduàJoaquim Raduà
Joaquim Raduà
Eduard VietaEduard Vieta
Eduard Vieta
RSRussell Shinohara
Russell Shinohara
PKPeter Kochunov
Peter Kochunov
YQYann Quide
Yann Quide
JPJulian Pineda-Zapata
Julian Pineda-Zapata
A common limitation of neuroimaging studies is their small sample sizes. To overcome this hurdle, the Enhancing Neuro Imaging Genetics through Meta-Analysis (ENIGMA) Consortium combines neuroimaging data from many institutions worldwide. However, this introduces heterogeneity due to different scanning devices and sequences. ENIGMA projects commonly address this heterogeneity with random-effects meta-analysis or mixed-effects mega-analysis. Here we tested whether the batch adjustment method, ComBat, can further reduce site-related heterogeneity and thus increase statistical power. We conducted random-effects meta-analyses, mixed-effects mega-analyses and ComBat mega-analyses to compare cortical thickness, surface area and subcortical volumes between 2897 individuals with a diagnosis of schizophrenia and 3141 healthy controls from 33 sites. Specifically, we compared the imaging data between individuals with schizophrenia and healthy controls, covarying for age and sex. The use of ComBat substantially increased the statistical significance of the findings as compared to random-effects meta-analyses. The findings were more similar when comparing ComBat with mixed-effects mega-analysis, although ComBat still slightly increased the statistical significance. ComBat also showed increased statistical power when we repeated the analyses with fewer sites. Results were nearly identical when we applied the ComBat harmonization separately for cortical thickness, cortical surface area and subcortical volumes. Therefore, we recommend applying the ComBat function to attenuate potential effects of site in ENIGMA projects and other multi-site structural imaging work. We provide easy-to-use functions in R that work even if imaging data are partially missing in some brain regions, and they can be trained with one data set and then applied to another (a requirement for some analyses such as machine learning).

18 February 2021 in European Psychiatry
Verified
Journal Article
Open access
PDF file
SGS. Galderisi
S. Galderisi
Armida MucciArmida Mucci
Armida Mucci
SDS. Dollfus
S. Dollfus
MNM. Nordentoft
M. Nordentoft
PFP. Falkai
P. Falkai
WGW. Gaebel
W. Gaebel
Background: During the last decades, a renewed interest for negative symptoms (NS) was brought about by the increased awareness that they interfere severely with real-life functioning, particularly when they are primary and persistent. Methods: In this guidance paper, we provide a systematic review of the evidence and elaborate several recommendations for the conceptualization and assessment of NS in clinical trials and practice. Results: Expert consensus and systematic reviews have provided guidance for the optimal assessment of primary and persistent negative symptoms; second-generation rating scales, which provide a better assessment of the experiential domains, are available; however, NS are still poorly assessed both in research and clinical settings. This European Psychiatric Association (EPA) guidance recommends the use of persistent negative symptoms (PNS) construct in the context of clinical trials and highlights the need for further efforts to make the definition of PNS consistent across studies in order to exclude as much as possible secondary negative symptoms. We also encourage clinicians to use second-generation scales, at least to complement first-generation ones. The EPA guidance further recommends the evidence-based exclusion of several items included in first-generation scales from any NS summary or factor score to improve NS measurement in research and clinical settings. Self-rated instruments are suggested to further complement observer-rated scales in NS assessment. Several recommendations are provided for the identification of secondary negative symptoms in clinical settings. Conclusions: The dissemination of this guidance paper may promote the development of national guidelines on negative symptom assessment and ultimately improve the care of people with schizophrenia.

1 May 2009 in American Journal of Psychiatry
Verified
Journal Article
Closed access
AZArne Zastrow
Arne Zastrow
SKStefan Kaiser
Stefan Kaiser
CSChristoph Stippich
Christoph Stippich
SWStephan Walther
Stephan Walther
WHWolfgang Herzog
Wolfgang Herzog
HFHans-Christoph Friederich
Hans-Christoph Friederich

1 May 2010 in Schizophrenia Research
Verified
Journal Article
Closed access
JSJoe J. Simon
Joe J. Simon
ABArmin Biller
Armin Biller
SWStephan Walther
Stephan Walther
DRDaniela Roesch-Ely
Daniela Roesch-Ely
CSChristoph Stippich
Christoph Stippich
SKStefan Kaiser
Stefan Kaiser

1 August 2017 in Schizophrenia Research
Verified
Journal Article
Closed access
MKMatthias Kirschner
Matthias Kirschner
AAAndré Aleman
André Aleman
SKStefan Kaiser
Stefan Kaiser